HEADER TRANSFERASE 30-OCT-02 1J04 TITLE STRUCTURAL MECHANISM OF ENZYME MISTARGETING IN HEREDITARY KIDNEY STONE TITLE 2 DISEASE IN VITRO COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALANINE--GLYOXYLATE AMINOTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERINE--PYRUVATE AMINOTRANSFERASE; COMPND 5 EC: 2.6.1.51, 2.6.1.44; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109 KEYWDS TRANSFERASE, AMINOTRANSFERASE, PYRIDOXAL PHOSPHATE EXPDTA X-RAY DIFFRACTION AUTHOR X.ZHANG,S.DJORDJEVIC,M.BARTLAM,S.YE,Z.RAO,C.J.DANPURE REVDAT 8 15-NOV-23 1J04 1 REMARK REVDAT 7 25-OCT-23 1J04 1 REMARK REVDAT 6 10-NOV-21 1J04 1 REMARK SEQADV LINK REVDAT 5 25-JUL-18 1J04 1 COMPND SOURCE REMARK SEQADV REVDAT 4 13-JUL-11 1J04 1 VERSN REVDAT 3 28-APR-10 1J04 1 JRNL REVDAT 2 24-FEB-09 1J04 1 VERSN REVDAT 1 11-NOV-03 1J04 0 JRNL AUTH S.DJORDJEVIC,X.ZHANG,M.BARTLAM,S.YE,Z.RAO,C.J.DANPURE JRNL TITL STRUCTURAL IMPLICATIONS OF A G170R MUTATION OF JRNL TITL 2 ALANINE:GLYOXYLATE AMINOTRANSFERASE THAT IS ASSOCIATED WITH JRNL TITL 3 PEROXISOME-TO-MITOCHONDRION MISTARGETING. JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 66 233 2010 JRNL REFN ESSN 1744-3091 JRNL PMID 20208150 JRNL DOI 10.1107/S1744309109054645 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 17989 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1763 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 201 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.90900 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 5.81700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.90900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1J04 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1000005462. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18539 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.60 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.50 REMARK 200 R MERGE FOR SHELL (I) : 0.48700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1H0C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, NA HEPES, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.41150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 44.74550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 44.74550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.70575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 44.74550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 44.74550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 107.11725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 44.74550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.74550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.70575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 44.74550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.74550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 107.11725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.41150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 89.49100 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -89.49100 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -142.82300 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 LYS A 391 REMARK 465 LEU A 392 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 122 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 137 CG CD OE1 NE2 REMARK 470 LYS A 177 CB CG CD CE NZ REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 LYS A 390 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 5 -158.27 -102.89 REMARK 500 PRO A 28 8.88 -61.07 REMARK 500 GLN A 69 63.45 73.94 REMARK 500 SER A 99 102.54 53.25 REMARK 500 LYS A 128 135.81 -179.08 REMARK 500 LYS A 147 56.23 35.44 REMARK 500 GLU A 171 -72.34 -26.69 REMARK 500 ARG A 175 -6.00 -56.35 REMARK 500 MET A 195 -73.94 -42.07 REMARK 500 LLP A 209 -108.26 -92.34 REMARK 500 HIS A 261 -77.19 -116.00 REMARK 500 GLN A 282 -71.33 -58.10 REMARK 500 ALA A 328 -68.03 -23.70 REMARK 500 ALA A 368 74.52 -68.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AOA A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1009 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H0C RELATED DB: PDB REMARK 900 1H0C CONTAINS THE STRUCTURE OF NORMAL AGT DBREF 1J04 A 1 392 UNP P21549 SPYA_HUMAN 1 392 SEQADV 1J04 ARG A 170 UNP P21549 GLY 170 ENGINEERED MUTATION SEQRES 1 A 392 MET ALA SER HIS LYS LEU LEU VAL THR PRO PRO LYS ALA SEQRES 2 A 392 LEU LEU LYS PRO LEU SER ILE PRO ASN GLN LEU LEU LEU SEQRES 3 A 392 GLY PRO GLY PRO SER ASN LEU PRO PRO ARG ILE MET ALA SEQRES 4 A 392 ALA GLY GLY LEU GLN MET ILE GLY SER MET SER LYS ASP SEQRES 5 A 392 MET TYR GLN ILE MET ASP GLU ILE LYS GLU GLY ILE GLN SEQRES 6 A 392 TYR VAL PHE GLN THR ARG ASN PRO LEU THR LEU VAL ILE SEQRES 7 A 392 SER GLY SER GLY HIS CYS ALA LEU GLU ALA ALA LEU VAL SEQRES 8 A 392 ASN VAL LEU GLU PRO GLY ASP SER PHE LEU VAL GLY ALA SEQRES 9 A 392 ASN GLY ILE TRP GLY GLN ARG ALA VAL ASP ILE GLY GLU SEQRES 10 A 392 ARG ILE GLY ALA ARG VAL HIS PRO MET THR LYS ASP PRO SEQRES 11 A 392 GLY GLY HIS TYR THR LEU GLN GLU VAL GLU GLU GLY LEU SEQRES 12 A 392 ALA GLN HIS LYS PRO VAL LEU LEU PHE LEU THR HIS GLY SEQRES 13 A 392 GLU SER SER THR GLY VAL LEU GLN PRO LEU ASP GLY PHE SEQRES 14 A 392 ARG GLU LEU CYS HIS ARG TYR LYS CYS LEU LEU LEU VAL SEQRES 15 A 392 ASP SER VAL ALA SER LEU GLY GLY THR PRO LEU TYR MET SEQRES 16 A 392 ASP ARG GLN GLY ILE ASP ILE LEU TYR SER GLY SER GLN SEQRES 17 A 392 LLP ALA LEU ASN ALA PRO PRO GLY THR SER LEU ILE SER SEQRES 18 A 392 PHE SER ASP LYS ALA LYS LYS LYS MET TYR SER ARG LYS SEQRES 19 A 392 THR LYS PRO PHE SER PHE TYR LEU ASP ILE LYS TRP LEU SEQRES 20 A 392 ALA ASN PHE TRP GLY CYS ASP ASP GLN PRO ARG MET TYR SEQRES 21 A 392 HIS HIS THR ILE PRO VAL ILE SER LEU TYR SER LEU ARG SEQRES 22 A 392 GLU SER LEU ALA LEU ILE ALA GLU GLN GLY LEU GLU ASN SEQRES 23 A 392 SER TRP ARG GLN HIS ARG GLU ALA ALA ALA TYR LEU HIS SEQRES 24 A 392 GLY ARG LEU GLN ALA LEU GLY LEU GLN LEU PHE VAL LYS SEQRES 25 A 392 ASP PRO ALA LEU ARG LEU PRO THR VAL THR THR VAL ALA SEQRES 26 A 392 VAL PRO ALA GLY TYR ASP TRP ARG ASP ILE VAL SER TYR SEQRES 27 A 392 VAL ILE ASP HIS PHE ASP ILE GLU ILE MET GLY GLY LEU SEQRES 28 A 392 GLY PRO SER THR GLY LYS VAL LEU ARG ILE GLY LEU LEU SEQRES 29 A 392 GLY CYS ASN ALA THR ARG GLU ASN VAL ASP ARG VAL THR SEQRES 30 A 392 GLU ALA LEU ARG ALA ALA LEU GLN HIS CYS PRO LYS LYS SEQRES 31 A 392 LYS LEU MODRES 1J04 LLP A 209 LYS HET LLP A 209 24 HET AOA A1001 6 HET GOL A1002 6 HET GOL A1003 6 HET GOL A1004 6 HET GOL A1006 6 HET GOL A1007 6 HET GOL A1008 6 HET GOL A1009 6 HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM AOA (AMINOOXY)ACETIC ACID HETNAM GOL GLYCEROL HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 LLP C14 H22 N3 O7 P FORMUL 2 AOA C2 H5 N O3 FORMUL 3 GOL 7(C3 H8 O3) FORMUL 10 HOH *113(H2 O) HELIX 1 1 PRO A 11 LYS A 16 5 6 HELIX 2 2 PRO A 34 GLY A 41 1 8 HELIX 3 3 SER A 50 GLN A 69 1 20 HELIX 4 4 SER A 81 LEU A 94 1 14 HELIX 5 5 GLY A 106 ILE A 119 1 14 HELIX 6 6 THR A 135 LYS A 147 1 13 HELIX 7 7 GLY A 168 ARG A 175 1 8 HELIX 8 8 SER A 223 ARG A 233 1 11 HELIX 9 9 ASP A 243 TRP A 251 1 9 HELIX 10 10 PRO A 265 GLY A 283 1 19 HELIX 11 11 GLY A 283 LEU A 305 1 23 HELIX 12 12 ASP A 331 ASP A 344 1 14 HELIX 13 13 LEU A 351 THR A 355 5 5 HELIX 14 14 LEU A 364 ALA A 368 5 5 HELIX 15 15 THR A 369 CYS A 387 1 19 SHEET 1 A 2 LEU A 24 LEU A 25 0 SHEET 2 A 2 ILE A 345 GLU A 346 1 O GLU A 346 N LEU A 24 SHEET 1 B 7 THR A 75 ILE A 78 0 SHEET 2 B 7 SER A 218 PHE A 222 -1 O SER A 218 N ILE A 78 SHEET 3 B 7 ILE A 202 GLY A 206 -1 N SER A 205 O LEU A 219 SHEET 4 B 7 LEU A 179 ASP A 183 1 N VAL A 182 O ILE A 202 SHEET 5 B 7 LEU A 150 THR A 154 1 N LEU A 151 O LEU A 181 SHEET 6 B 7 PHE A 100 VAL A 102 1 N LEU A 101 O LEU A 150 SHEET 7 B 7 VAL A 123 PRO A 125 1 O HIS A 124 N PHE A 100 SHEET 1 C 2 VAL A 321 ALA A 325 0 SHEET 2 C 2 VAL A 358 GLY A 362 -1 O ILE A 361 N THR A 322 LINK C GLN A 208 N LLP A 209 1555 1555 1.33 LINK C LLP A 209 N ALA A 210 1555 1555 1.34 CISPEP 1 GLY A 29 PRO A 30 0 -0.03 SITE 1 AC1 5 PRO A 28 GLY A 29 LLP A 209 MET A 348 SITE 2 AC1 5 ARG A 360 SITE 1 AC2 4 LEU A 24 ARG A 71 ASP A 196 PHE A 343 SITE 1 AC3 4 LYS A 228 GLN A 290 ARG A 370 GLU A 371 SITE 1 AC4 4 SER A 19 ASP A 52 GLN A 55 GLU A 59 SITE 1 AC5 3 GLN A 110 ARG A 111 TRP A 246 SITE 1 AC6 1 LEU A 278 SITE 1 AC7 4 LEU A 7 ASN A 22 ARG A 170 ASP A 196 SITE 1 AC8 3 GLN A 137 GLU A 138 GLU A 141 CRYST1 89.491 89.491 142.823 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011174 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011174 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007002 0.00000